Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Neuropsychiatric Disease and Treatment|July 16, 2025
An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT StudyJustin J Chapman, Dan Siskind, Alison R Yung, et al.
Cancer Cell|April 9, 2008
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cellsPeggy Kirstetter, Mikkel B Schuster, Oksana Bereshchenko, et al.
JAMA Network Open|February 4, 2022
Effect of Clinical Decision Support at Community Health Centers on the Risk of Cardiovascular Disease: A Cluster Randomized Clinical TrialRachel Gold, Annie E Larson, JoAnn M Sperl-Hillen, et al.
Scientific Reports|June 7, 2022
A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxisMonir Ejemel, Todd G Smith, Lauren Greenberg, et al.
JCO Oncology Practice|October 25, 2021
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO RegistryKathryn F Mileham, Suanna S Bruinooge, Charu Aggarwal, et al.
The Journal of Clinical Investigation|December 18, 2019
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor modelsLucia Nappi, Adeleke H Aguda, Nader Al Nakouzi, et al.
JAMA Network Open|December 28, 2021
Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical TrialFiona Gaughran, Dominic Stringer, Gabriella Wojewodka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 12, 2025
CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapyBernhard Lehnertz, Maéva Langouët, Sophie Corneau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled StudyNithya J Gogtay, Renuka Munshi, D H Ashwath Narayana, et al.
British Journal of Clinical Pharmacology|April 25, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and allelesDaniel L Hertz, Anna C Snavely, Howard L McLeod, et al.
Pageof 11